Pancreatic Cancer Screening and Early Detection: Where Are We Now?
Abstract
Screening for pancreatic cancer with imaging techniques in high-risk individuals—including patients with a genetic predisposition, a family history, or precursor lesions—is critical for improving early detection and survival outcomes, and multimodal strategies that integrate AI-enhanced radiomics with liquid biopsy hold promise for developing efficient and effective screening programs tailored to high-risk populations.
// Source
Authors: Shravya Srinivas Rao, Soumyadeep Ghosh, Ajit H. Goenka, Elizabeth M. Hecht, Chenchan Huang, Zhen J. Wang, Carlos F. Fernandez-del Castillo, Daniel C. Chung, Suresh T. Chari, Avinash Kambadakone
Institutions: University of California, San Francisco, Cornell University, The University of Texas MD Anderson Cancer Center, New York University, Massachusetts General Hospital, Mayo Clinic, Weill Cornell Medicine, University of California System